NCT07651345

Brief Summary

Breast cancer is the most common cancer among women in Singapore, accounting for nearly 30% of all female cancers. While regular biennial mammography can reduce mortality, screening rates in Singapore remain low at 34.7%; well below the 70% threshold required for population-level impact. Despite a national screening program in place since 2002, uptake continues to be hindered by psychological, cultural, and logistical barriers. Although various studies have explored different behavioural interventions to boost mammogram uptake; ranging from reminders (traditional mailers, phone calls, text messages) and education to financial incentives, their effectiveness varies by population and context. Furthermore, few large-scale, prospective studies have been conducted locally. Prior research in Singapore is either outdated or limited in scope, and there is a particular lack of rigorous trials evaluating behavioral interventions tailored to women who have defaulted on screening, who faces distinct psychological and behavioral barriers; ranging from low perceived risk and fear, to false reassurance from prior normal results or lack of reminders, or had bad experience (procedural pain or prior false positive results) during last mammogram. Engaging these women is critical, yet challenging, and failure to do so undermines efforts to achieve broad population coverage. The REMIND Study addresses this critical gap by evaluating five pragmatic and scalable outreach strategies to increase mammogram uptake among women who had their last screening more than 2 years ago and are currently overdue. Through a large, randomized controlled trial, the study will generate much-needed local evidence on what works to reengage these women. Findings will directly inform national screening policies and the design of future outreach efforts tailored to Singapore's diverse population.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12,750

participants targeted

Target at P75+ for not_applicable

Timeline
17mo left

Started Mar 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Mar 2026Dec 2027

Study Start

First participant enrolled

March 9, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 21, 2026

Completed
26 days until next milestone

First Posted

Study publicly available on registry

June 16, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

June 16, 2026

Status Verified

April 1, 2026

Enrollment Period

10 months

First QC Date

May 21, 2026

Last Update Submit

June 10, 2026

Conditions

Keywords

MammographyBehavioural InterventionBreast cancer detectionearly detectionMailed reminderCancer ScreeningBreast cancer

Outcome Measures

Primary Outcomes (1)

  • Comparison of proportion of participants completing surveillance mammography within 4 months after intervention assignment between interventional arms (2-5) and control arm (Arm 1)

    The proportion of women who undergo surveillance mammography within 4 months of receiving the study intervention/reminder will be compared between Arm 1 (control) and Arms 2-5. Mammogram completion will be confirmed through electronic medical records. Results will be reported as the percentage of participants completing mammography in each study arm. Unit of Measure: Percentage of participants (%)

    4 months from the time participants receive the intervention/reminder

Secondary Outcomes (3)

  • Association between participant characteristics and completion of surveillance mammography within 4 months

    4 months from the time participants receive the intervention/reminder

  • Post-trial telephone survey

    1-2 months post-trial

  • Mammogram uptake at 6 and 12 months post-trial

    6 and 12 months from the time participants received the first mailed reminder

Study Arms (5)

Control Arm (Arm 1)

NO INTERVENTION

Does not receive any reminder to go for mammogram

Arm 2: One mailed reminder

EXPERIMENTAL

Receives a single mail reminder

Behavioral: Arm 2: One mailed reminder

Arm 3: Two mailed reminders

EXPERIMENTAL

Receives two mail reminders, 4 weeks apart

Behavioral: Arm 3: Two mailed reminders

Arm 4: Mailed Reminder with Prescheduled Appointment

EXPERIMENTAL

Receives a mailed reminder with prescheduled appointment

Behavioral: Arm 4: Mailed reminder with prescheduled appointment

Arm 5: Mailed reminder with enhanced messaging

EXPERIMENTAL

Receives mailed reminder with enhanced messaging

Behavioral: Arm 5: Mailed reminder

Interventions

Receives a mailed reminder + follow-up mailed reminder, 4 weeks after the first

Arm 3: Two mailed reminders

Receives one mailed reminder with enhanced messaging motivating recipient to undergo screening

Arm 5: Mailed reminder with enhanced messaging

Receives a mailed reminder with basic information about breast cancer and instructions on scheduling a mammogram

Arm 2: One mailed reminder

Receives one mailed reminder with a pre-scheduled appointment, with instructions to change appointment

Arm 4: Mailed Reminder with Prescheduled Appointment

Eligibility Criteria

Age50 Years - 69 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemales only
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Singaporean citizen
  • Age 50-69
  • Registered as a patient at the National University Hospital
  • Registered and active user of NUHS App
  • Signed up with Healthier SG with a primary care provider within the NUHS Primary Care Network
  • Must be defaulted repeat screeners : Must have done one prior mammogram screening but not in the past 2 years

You may not qualify if:

  • Diagnosis of breast cancer in EPIC
  • Mammogram done in the past 24 months in EPIC

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National University Hospital Singapore

Singapore, Singapore

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2026

First Posted

June 16, 2026

Study Start

March 9, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

June 16, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations